Is the Elephant in the room re. the disappointing SP at the moment something to do with the Mesoblast disaster? Their failure with FDA approval has cost their SP to crash over 60%. Would not funds holding MSB have had to ditch in order to alleviate losses there and to make their overall
performance less bad they would have been forced to realise their profits made in NEU by selling.
If so how long would this take to shake out?
Is the Elephant in the room re. the disappointing SP at the...
-
- There are more pages in this discussion • 4,320 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.94 |
Change
-0.040(0.20%) |
Mkt cap ! $2.548B | |||
| Open | High | Low | Value | Volume |
| $19.92 | $20.04 | $19.51 | $4.745M | 239.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 198 | $19.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.94 | 1256 | 2 |
View Market Depth
| Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |